Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Washington State partners with VisualVault to modernize forest practices management The Washington State Department of Natural Resources (DNR) has taken a significant step toward modernizing its operations by… byPallavi MadhirajuJanuary 23, 2025